These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 537965)

  • 1. Iron overload despite partial gastrectomy.
    Parfrey PS; Turnbull AL; Pollock DJ; Barnett M
    Postgrad Med J; 1979 Oct; 55(648):747-50. PubMed ID: 537965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemochromatosis in patients with beta-thalassaemia trait.
    Piperno A; Mariani R; Arosio C; Vergani A; Bosio S; Fargion S; Sampietro M; Girelli D; Fraquelli M; Conte D; Fiorelli G; Camaschella C
    Br J Haematol; 2000 Dec; 111(3):908-14. PubMed ID: 11122155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload in beta-thalassaemia minor. A family study.
    Parfrey PS; Barnett M; Sachs JA; Pollock DJ; Turnbull AL
    Scand J Haematol; 1981 Oct; 27(4):294-302. PubMed ID: 7346995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iron overload in a beta thalassemia heterozygote of the intermediate type in a subject of Alsation origin. Results of iron chelation treatment].
    North ML; Lang JM; Bergerat JP; Giron C; Oberling F; Mayer S
    Nouv Rev Fr Hematol (1978); 1984; 26(5):317-21. PubMed ID: 6334273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Thursz M
    Gut; 2007 May; 56(5):613-4. PubMed ID: 17440181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous excretion of iron and ferritin (through Al-hijamah) as a novel treatment for iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia.
    El Sayed SM; Abou-Taleb A; Mahmoud HS; Baghdadi H; Maria RA; Ahmed NS; Nabo MM
    Med Hypotheses; 2014 Aug; 83(2):238-46. PubMed ID: 24857772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noniatrogenic haemochromatosis in congenital dyserythropoietic anaemia type II is not related to C282Y and H63D mutations in the HFE gene: report on two brothers.
    Van Steenbergen W; Matthijs G; Roskams T; Fevery J
    Acta Clin Belg; 2002; 57(2):79-84. PubMed ID: 12152243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis.
    Güngör T; Rohrbach E; Solem E; Kaltwasser JP; Kornhuber B
    Arch Dis Child; 1996 Apr; 74(4):323-7. PubMed ID: 8669933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deferasirox for managing iron overload in people with thalassaemia.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Motschall E; Niemeyer CM; Bassler D
    Cochrane Database Syst Rev; 2012 Feb; (2):CD007476. PubMed ID: 22336831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload.
    Ruefer A; Bapst C; Benz R; Bremerich J; Cantoni N; Infanti L; Samii K; Schmid M; Vallée JP
    Swiss Med Wkly; 2017; 147():w14550. PubMed ID: 29120023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited haemochromatosis with C282Y mutation in a patient with alpha-thalassaemia: a treatment dilemma.
    Al Qasem MA; Hanna F; Vithanarachchi US; Khalafallah AA
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29301806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffective erythropoiesis and regulation of iron status in iron loading anaemias.
    Camaschella C; Nai A
    Br J Haematol; 2016 Feb; 172(4):512-23. PubMed ID: 26491866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant primary hemochromatosis and beta-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine.
    Cesana M; Mandelli C; Tiribelli C; Bianchi PA; Conte D
    Am J Gastroenterol; 1989 Feb; 84(2):150-2. PubMed ID: 2916524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemochromatosis associated with hereditary spherocytosis].
    López DE; Kohan M; Ferreño D; Raffa MP; Prytyka A
    Acta Gastroenterol Latinoam; 1997; 27(4):267-70. PubMed ID: 9580054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adiastole caused by a secondary cardiac hemochromatosis. Successful treatment with an iron chelating agent].
    Baudouy P; Lombrail P; Azancot I; Piekarski A; Martin E; Slama R
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1240-6. PubMed ID: 6418103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thalassemia minor with iron overload: genetic and clinical study of a family].
    Queipo de Llano MP; Yebra M; Moreno M; Lacoma F; Gea JC; Berrocal E
    Med Clin (Barc); 1991 Nov; 97(17):660-2. PubMed ID: 1762461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC; Lee PL; West C; Bottomley SS
    Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.